Offer - Urjas Oil for just ₹ 1 X
Olmesar M 25 Tablet is a commercial drug that is prescribed in the form of Tablet. Other than this, Olmesar M 25 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Olmesar M 25 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Olmesar M 25 Tablet also has some side effects, the most common being Upper respiratory tract infection, Slow heart rate (pulse). Some other side effects of Olmesar M 25 Tablet have been listed ahead. Such side effects of Olmesar M 25 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Olmesar M 25 Tablet's effect during pregnancy is Severe and Mild while nursing. It is important to know if Olmesar M 25 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Olmesar M 25 Tablet related warnings section.
Olmesar M 25 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Bradycardia (Slow Heart Rate) are examples of such conditions. Other contraindications of Olmesar M 25 Tablet have been discussed in the sections ahead.
Drug reaction of Olmesar M 25 Tablet with other medicines has been reported. See below for a complete list.
You should also be aware that Olmesar M 25 Tablet is not safe while driving, and is not addiction.
Olmesar M 25 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmesar M 25 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Olmesar M. If you are pregnant, do not take Olmesar M without a doctor's advice.
Is the use of Olmesar M 25 Tablet safe during breastfeeding?
Olmesar M has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olmesar M 25 Tablet on the Kidneys?
Olmesar M does not damage the kidneys.
What is the effect of Olmesar M 25 Tablet on the Liver?
Very few cases of side effects of Olmesar M on the liver have been reported.
What is the effect of Olmesar M 25 Tablet on the Heart?
Very few cases of side effects of Olmesar M on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Olmesar M 25 Tablet unless your doctor advises you to do so -
Is this Olmesar M 25 Tablet habit forming or addictive?
No, there is no any evidence that Olmesar M 25 Tablet is addictive.
Interaction between Food and Olmesar M 25 Tablet
Olmesar M 25 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Olmesar M 25 Tablet
Consuming Olmesar M 25 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850